XML 24 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net loss $ (92,262) $ (111,441) $ (150,920)
Adjustments to reconcile net loss to net cash provided by (used by) operating activities:      
Stock-based compensation 39,045 43,387 38,830
Depreciation expense and amortization of intangible assets 10,030 9,473 7,297
Lease impairment charges 5,462 0 0
Bad debt expense 1,760 1,091 1,298
Amortization of debt issuance costs 589 444 43
Loss on disposal of property and equipment 0 0 3
Benefit for deferred income taxes (899) (1,541) (1,089)
Foreign currency transaction losses (gains), net 16,745 (12,263) 0
Changes in assets and liabilities:      
Accounts receivable (28,353) (1,868) (37,922)
Prepaid expenses and other assets 16,551 (54,753) (2,027)
Deferred commissions (3,144) (8,043) (12,298)
Accounts payable and accrued expenses (871) (1,394) (3,289)
Accrued compensation and related benefits (2,947) (3,157) 6,582
Other current and non-current liabilities (1,478) (1,134) (264)
Deferred revenue 49,309 28,668 47,534
Operating lease assets and liabilities (2,659) 2,089 (329)
Net cash provided by (used by) operating activities 6,878 (110,442) (106,551)
Cash flows from investing activities:      
Proceeds from maturities of investments 20,038 91,670 84,642
Payments for investments (51,630) (53,443) (65,283)
Purchases of property and equipment (3,798) (9,637) (9,095)
Net cash (used by) provided by investing activities (35,390) 28,590 10,264
Cash flows from financing activities:      
Proceeds from borrowings 50,000 92,000 120,000
Payments for debt issuance costs (463) (276) (1,940)
Debt repayments (6,250) (3,563) (625)
Repurchase of common stock (50,019) 0 0
Payments for employee taxes related to the net share settlement of equity awards (7,987) (9,748) 0
Proceeds from exercise of common stock options 14,461 752 25,432
Net cash (used by) provided by financing activities (258) 79,165 142,867
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash (2,029) 1,657 (159)
Net (decrease) increase in cash, cash equivalents, and restricted cash (30,799) (1,030) 46,421
Cash, cash equivalents, and restricted cash at beginning of period 149,351 150,381 103,960
Cash, cash equivalents, and restricted cash at end of period 118,552 149,351 150,381
Supplemental cash flow information:      
Cash paid for interest 22,574 16,906 1,671
Cash paid for income taxes 3,334 3,999 1,239
Supplemental non-cash investing and financing information:      
Accrued capital expenditures $ 155 $ 654 $ 1,774